Jan Storek

13.2k total citations · 1 hit paper
187 papers, 7.6k citations indexed

About

Jan Storek is a scholar working on Hematology, Immunology and Epidemiology. According to data from OpenAlex, Jan Storek has authored 187 papers receiving a total of 7.6k indexed citations (citations by other indexed papers that have themselves been cited), including 117 papers in Hematology, 79 papers in Immunology and 49 papers in Epidemiology. Recurrent topics in Jan Storek's work include Hematopoietic Stem Cell Transplantation (111 papers), T-cell and B-cell Immunology (42 papers) and Cytomegalovirus and herpesvirus research (38 papers). Jan Storek is often cited by papers focused on Hematopoietic Stem Cell Transplantation (111 papers), T-cell and B-cell Immunology (42 papers) and Cytomegalovirus and herpesvirus research (38 papers). Jan Storek collaborates with scholars based in Canada, United States and Australia. Jan Storek's co-authors include Michael Boeckh, Hermann Einsele, Rainer Storb, Ronald E. Gress, Jo‐Anne H. Young, David G. Maloney, John R. Wingard, Tom Chiller, Kent A. Sepkowitz and Marcie Tomblyn and has published in prestigious journals such as Blood, PLoS ONE and Neurology.

In The Last Decade

Jan Storek

173 papers receiving 7.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective

2009 1.1k citations Marcie Tomblyn, Tom Chiller et al. Biology of Blood and Marrow Transplantation profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Jan Storek	4.1k	3.0k	2.4k	2.0k	875	187	7.6k
Richard J. O’Reilly	3.9k 1.0×	5.0k 1.6×	2.4k 1.0×	3.8k 1.9×	652 0.7×	295	10.7k
Hildegard Greinix	5.6k 1.4×	2.6k 0.8×	1.4k 0.6×	1.9k 0.9×	1.2k 1.3×	244	8.9k
Jacek Winiarski	5.0k 1.2×	3.2k 1.1×	1.3k 0.5×	1.4k 0.7×	2.4k 2.8×	147	8.1k
Paul Veys	3.5k 0.8×	3.0k 1.0×	1.6k 0.7×	1.9k 0.9×	748 0.9×	186	7.7k
Régis Peffault de Latour	4.5k 1.1×	3.7k 1.2×	1.2k 0.5×	1.8k 0.9×	586 0.7×	384	8.6k
Montserrat Rovira	2.5k 0.6×	1.0k 0.3×	1.9k 0.8×	2.1k 1.0×	1.1k 1.3×	218	6.7k
H. G. Prentice	3.9k 0.9×	2.3k 0.8×	1.8k 0.8×	1.6k 0.8×	1.0k 1.2×	174	7.2k
Rafael F. Duarte	3.3k 0.8×	1.0k 0.3×	1.3k 0.5×	1.8k 0.9×	963 1.1×	163	6.1k
Liisa Volin	4.6k 1.1×	1.2k 0.4×	1.3k 0.5×	1.8k 0.9×	709 0.8×	210	7.0k
Pierre Tiberghien	2.2k 0.5×	3.1k 1.0×	1.2k 0.5×	1.8k 0.9×	720 0.8×	296	8.6k

Countries citing papers authored by Jan Storek

Since Specialization

Citations

This map shows the geographic impact of Jan Storek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Storek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Storek more than expected).

Fields of papers citing papers by Jan Storek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Storek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Storek. The network helps show where Jan Storek may publish in the future.

Co-authorship network of co-authors of Jan Storek

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Storek. A scholar is included among the top collaborators of Jan Storek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Storek. Jan Storek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Puckrin, Robert, et al.. (2025). Impact of Underlying Disease and Total Body Irradiation on the Incidence of Graft-Versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy. 31(3). 176.e1–176.e8.

Currie, Gillian, Jan Storek, Karen V. MacDonald, et al.. (2024). Measuring Patient Preferences to Inform Clinical Trial Design: An Example in Rheumatoid Arthritis. Patient. 18(2). 161–171.

Béland, Benjamin, Jan Storek, Christopher Hahn, et al.. (2024). Refractory myasthenia gravis treated with autologous hematopoietic stem cell transplantation. Annals of Clinical and Translational Neurology. 12(1). 56–68.

Walker, Irwin, Mohamed Elemary, Mahmoud Elsawy, et al.. (2024). A Randomized Pilot Trial Comparing Anti-Thymocyte Globulin (ATG) with ATG Plus Post Transplant Cyclophosphamide (PTCy) for Prophylaxis Against Acute and Chronic Graft Versus Host Disease (GVHD) in Matched Donor Hematopoietic Cell Transplants (HCT). Blood. 144(Supplement 1). 3519–3519.

Storek, Jan & Julian Lindsay. (2023). Rituximab for posttransplant lymphoproliferative disorder – therapeutic, preemptive, or prophylactic?. Bone Marrow Transplantation. 59(1). 6–11. 2 indexed citations

Socié, Gèrard, Pere Barba, Arie Barlev, et al.. (2023). Outcomes for patients with EBV-positive PTLD post-allogeneic HCT after failure of rituximab-containing therapy. Bone Marrow Transplantation. 59(1). 52–58. 9 indexed citations

Puckrin, Robert, Mona Shafey, & Jan Storek. (2023). The role of allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia: A review. Frontiers in Oncology. 12. 1105779–1105779. 5 indexed citations

Béland, Benjamin, Christopher Hahn, Kareem Jamani, et al.. (2023). P.035 Autologous hematopoietic stem cell transplant for the treatment of refractory myasthenia gravis with anti-muscle specific kinase antibodies. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 50(s2). S67–S67.

Abedin, Tasnima, S. Ali Naqvi, Hua Shen, et al.. (2022). Cumulative incidence of subsequent malignancy after allo-HCT conditioned with or without low-dose total body irradiation. Blood Advances. 6(3). 767–773. 7 indexed citations

10.

Ghosh, Sunita, Catherine Leyshon, Deonne Dersch‐Mills, et al.. (2022). Toward optimization of cyclosporine concentration target to prevent acute graft‐versus‐host disease following myeloablative allogeneic stem cell transplant. Clinical Transplantation. 36(8). e14732–e14732. 4 indexed citations

11.

Williamson, Tyler, Kareem Jamani, Ahsan Chaudhry, et al.. (2021). Risk Factors for the Incidence of and the Mortality due to Post-Transplant Lymphoproliferative Disorder after Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy. 28(1). 53.e1–53.e10. 15 indexed citations

12.

Williamson, Tyler, Nicole L. Prokopishyn, Poonam Dharmani‐Khan, et al.. (2020). Hematopoietic cell transplant outcomes after myeloablative conditioning with fludarabine, busulfan, low‐dose total body irradiation, and rabbit antithymocyte globulin. Clinical Transplantation. 34(9). e14018–e14018. 11 indexed citations

13.

Pergam, Steven A., Janet A. Englund, Mini Kamboj, et al.. (2019). Preventing Measles in Immunosuppressed Cancer and Hematopoietic Cell Transplantation Patients: A Position Statement by the American Society for Transplantation and Cellular Therapy. Biology of Blood and Marrow Transplantation. 25(11). e321–e330. 19 indexed citations

14.

Cohen, Jeffrey A., Laura Baldassari, Harold Atkins, et al.. (2019). Autologous Hematopoietic Cell Transplantation for Treatment-Refractory Relapsing Multiple Sclerosis: Position Statement from the American Society for Blood and Marrow Transplantation. Biology of Blood and Marrow Transplantation. 25(5). 845–854. 72 indexed citations

15.

Williamson, Tyler, Raymond Tellier, Ahsan Chaudhry, et al.. (2017). Risk factors for post‐transplant lymphoproliferative disorder after Thymoglobulin‐conditioned hematopoietic cell transplantation. Clinical Transplantation. 32(1). 21 indexed citations

16.

Burton, Jodie, Jan Storek, Fiona Costello, Peter Duggan, & Luanne M. Metz. (2014). Autologous Hematopoietic Stem Cell Transplantation in Neuromyelitis Optica (P4.001). Neurology. 82(10_supplement). 1 indexed citations

17.

Tomblyn, Marcie, Tom Chiller, Hermann Einsele, et al.. (2009). Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective. Biology of Blood and Marrow Transplantation. 15(10). 1143–1238. 1149 indexed citations breakdown →

18.

Storek, Jan. (2008). Immunological reconstitution after hematopoietic cell transplantation – its relation to the contents of the graft. Expert Opinion on Biological Therapy. 8(5). 583–597. 47 indexed citations

19.

Lu, Hailing, Zhuo Zhao, Tomáš Kalina, Hans‐Peter Kiem, & Jan Storek. (2005). Interleukin-7 improves reconstitution of antiviral CD4 T cells. Biology of Blood and Marrow Transplantation. 11(2). 53–54. 2 indexed citations

20.

Storek, Jan, Stephen A. Ferrara, Carmen Rodrı́guez, & Andrew Saxon. (1992). Recovery of Mononuclear Cell Subsets after Bone Marrow Transplantation: Overabundance of CD4 ⁺ CD8 ⁺ Dual-Positive T Cells Reminiscent of Ontogeny. Journal of Hematotherapy. 1(4). 303–316. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact